Applied Therapeutics Inc’s recent filing unveils that its Chief Financial Officer Funtleyder Leslie D. unloaded Company’s shares for reported $78880.0 on Aug 22 ’24. In the deal valued at $5.83 per share,13,530 shares were sold. As a result of this transaction, Funtleyder Leslie D. now holds 277,911 shares worth roughly $0.36 million.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Then, Perfetti Riccardo sold 22,681 shares, generating $132,230 in total proceeds. Upon selling the shares at $5.83, the Chief Medical Officer now owns 986,853 shares.
Before that, Shendelman Shoshana sold 357,423 shares. Applied Therapeutics Inc shares valued at $2,208,874 were divested by the President and CEO at a price of $6.18 per share. As a result of the transaction, Shendelman Shoshana now holds 4,810,430 shares, worth roughly $6.16 million.
UBS downgraded its Applied Therapeutics Inc [APLT] rating to a Neutral from a a Buy in a research note published on December 02, 2024; the price target was decreased to $2 from $13. A number of analysts have revised their coverage, including RBC Capital Mkts’s analysts, who decreased its forecast for the stock in late November from “an Outperform” to “a Sector perform”. William Blair began covering APLT with “an Outperform” recommendation on July 31, 2024. RBC Capital Mkts started covering the stock on March 26, 2024. It rated APLT as “an Outperform”.
Price Performance Review of APLT
On Friday, Applied Therapeutics Inc [NASDAQ:APLT] saw its stock fall -0.78% to $1.28. Over the last five days, the stock has lost -36.95%. Applied Therapeutics Inc shares have fallen nearly -61.79% since the year began. Nevertheless, the stocks have fallen -46.89% over the past one year. While a 52-week high of $10.62 was reached on 11/11/24, a 52-week low of $1.20 was recorded on 12/06/24. SMA at 50 days reached $8.0319, while 200 days put it at $6.1074.
Levels Of Support And Resistance For APLT Stock
The 24-hour chart illustrates a support level at 1.1967, which if violated will result in even more drops to 1.1133. On the upside, there is a resistance level at 1.3467. A further resistance level may holdings at 1.4133. The Relative Strength Index (RSI) on the 14-day chart is 17.76, which indicates oversold technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -4.6615, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 98.92%. Stochastics %K at 1.33% indicates the stock is a buying.
How much short interest is there in Applied Therapeutics Inc?
A steep rise in short interest was recorded in Applied Therapeutics Inc stocks on 2024-11-15, dropping by -0.96 million shares to a total of 13.56 million shares. Yahoo Finance data shows the prior-month short interest on 2024-10-15 was 14.53 million shares. There was a decline of -7.1%, which implies that there is a negative sentiment for the stock.
The most recent change occurred on February 22, 2024 when Leerink Partners began covering the stock and recommended ‘”an Outperform”‘ rating along with a $12 price target.
